Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors.

体内 体外 细胞因子 医学 病理 免疫学 内科学 化学 内分泌学 生物 生物化学 生物技术
作者
Paul G. Braunschweiger,C S Johnson,Nirmal Kumar,V A Ord,Philip Furmanski
出处
期刊:PubMed 卷期号:48 (21): 6011-6 被引量:59
链接
标识
摘要

The antitumor effects of recombinant human interleukin 1 alpha (IL-1) were determined in RIF-1 and Panc02 murine solid tumors. Acute tumor hemorrhage was observed in both models as early as 3 h after a single 25 micrograms/kg IL-1 treatment and was quantitated by the intratumor accumulation of 59Fe-labeled erythrocytes (RBC). The IL-1-mediated hemorrhagic response was maximal 6-12 h after treatment and greater in Panc02 tumors than in RIF-1 tumors. Hemorrhagic responses to RIF-1 tumors growing in athymic nude mice were similar to those seen for RIF-1 tumors in C3H/HeJ mice. This acute vascular injury was accompanied by progressive edema in tumors but not in skin or muscle. In RIF-1 tumors, the extracell water volume at 12 h after IL-1 (395 microI/g) was nearly twice that in untreated controls (215 microI/g). IL-1 also produced marked reductions in tumor blood flow as early as 1 h after treatment. Maximal blood flow restriction was seen at 6 h after IL-1. Although restricted blood flow was observed in tumors for up to 48 h, IL-1 effects on muscle, liver, and skin blood flow were transient with recovery by 12 h after treatment. IL-1 (up to 0.4 ng/ml for 72 h) was not toxic to RIF-1 tissue culture cells in vitro, but 0.2 ng/ml IL-1, for 20 h, reduced the clonogenicity of RIF-1 cells in primary explant cultures by approximately 50%. In vivo, the clonogenic cellularity of RIF-1 tumors was reduced by 70%, 24 h after a single 25 micrograms/kg treatment. Increased clonogenic cell proliferation was observed at 24 h, and rapid repopulation of the clonogenic cell population was seen by 48 h. Although IL-1 transiently slowed the growth of RIF-1 tumors, no significant regrowth delay was observed. In Panc02 tumors, cell proliferation was also inhibited after IL-1. Recovery, however, was delayed and occurred more slowly than in RIF-1 tumors. Significant growth inhibition and regrowth delay (5 days) was observed in Panc02 tumors after a single IL-1 treatment. The results of these studies show that IL-1 has significant effects on the pathophysiology of both RIF-1 and Panc02 tumors in vivo. Further, our results indicate that these effects may be mediated through the activation of a non T-cell, adherent cell population residing in the tumor at the time of IL-1 treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Silence完成签到,获得积分10
刚刚
明芷蝶完成签到,获得积分10
刚刚
1秒前
wangdi应助默默的枫叶采纳,获得10
1秒前
LL完成签到,获得积分10
2秒前
YuexYue完成签到,获得积分10
2秒前
卷心菜完成签到,获得积分10
2秒前
许多鱼完成签到,获得积分10
3秒前
奶油泡fu完成签到 ,获得积分10
3秒前
科研通AI2S应助shizi采纳,获得10
3秒前
科研yu完成签到,获得积分10
4秒前
4秒前
4秒前
和谐安露完成签到,获得积分20
4秒前
5秒前
CJY完成签到 ,获得积分10
5秒前
Ava应助高不二采纳,获得10
5秒前
典雅的俊驰完成签到,获得积分10
5秒前
欢喜蛋挞完成签到,获得积分10
6秒前
快乐帽子完成签到,获得积分10
6秒前
斗羽完成签到,获得积分10
6秒前
luckily完成签到,获得积分10
7秒前
123456789发布了新的文献求助10
7秒前
科研通AI2S应助王九八采纳,获得10
8秒前
简爱发布了新的文献求助10
9秒前
LORI完成签到,获得积分10
9秒前
9秒前
VENTUS完成签到,获得积分10
9秒前
坚强莺发布了新的文献求助10
9秒前
读心理学导致的完成签到,获得积分10
10秒前
一路硕博应助arsenal采纳,获得10
10秒前
33完成签到,获得积分10
11秒前
瘦瘦洋葱发布了新的文献求助10
12秒前
LilyChen发布了新的文献求助10
12秒前
Noah完成签到,获得积分10
13秒前
13秒前
Ring完成签到 ,获得积分10
14秒前
超级涔雨完成签到,获得积分10
15秒前
啊娴仔发布了新的文献求助10
15秒前
lp完成签到,获得积分10
16秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3244993
求助须知:如何正确求助?哪些是违规求助? 2888654
关于积分的说明 8254529
捐赠科研通 2557066
什么是DOI,文献DOI怎么找? 1385741
科研通“疑难数据库(出版商)”最低求助积分说明 650214
邀请新用户注册赠送积分活动 626422